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Tracheal transplantation: is there lumen 
at the end of the tunnel?
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The good results achieved from vital organ transplantation around the world have motivated research on non-
vital organ transplantation. Recent reports on arm, ovary and airway transplantation have been published.1 On the 
other hand, tracheal transplantation is not a new idea. The simple anatomical structure of the trachea has misled re-
searchers since the first attempts at tracheal transplantation in the late 19th and early 20th century.2 Since then, a large 
number of surgical approaches for tracheal transplantation have been tried, with poor results.2 In spite of some an-
ecdotal reports, no clinically useful standard approach for tracheal transplantation has yet been achieved, and this 
remains under investigation. 
The development of a clinically useful approach relies on both a technically simpler way for tracheal graft vascu-
larization, and the avoidance of post-transplantation immunosuppressive therapy. Recently, tracheal graft vascular-
ization with topically-applied angiogenic factors has been reported.3 The use of angiogenic factors could obviate the 
need for complex surgical procedures for tracheal vascularization. Moreover, the recently described reepithelialization 
phenomena, and reports on improvements through tissue-engineering techniques, have raised the possibility of ab-
breviated or even absence of post-transplantation immunosuppressive therapy.4,5
What kind of patients would benefit from tracheal transplantation? The indications for tracheal transplantation 
would be long-length tracheal lesions for which tracheal resection with end-to-end anastomosis (tracheoplasty) was 
impossible.2 Long-length tracheal stenosis or malacia, chiefly secondary to airway intubation, would be the most 
common indication. Other indications would be tumors involving a large extent of the trachea, and relapsing trache-
al stenosis occurring after a previous attempt at surgical treatment. Currently, these patients are palliated with airway 
prostheses. Silastic T tubes are used in virtually all these cases. However, these tubes need to be changed on a regular 
basis, and complications with these devices occur in more than one third of such patients.6 
How many patients would benefit from tracheal transplantation in Brazil? According to data from the Brazilian 
National Health System (Sistema Único de Saúde, SUS), 1,688 airway interventions were performed in 2008.7 These 
interventions included 248 cases of airway stenting, 849 of tracheoplasty and 572 of laryngotracheoplasty. Among 
patients who undergo airway stenting, around 70% are thought to have long-length benign stenosis that is not man-
ageable with tracheoplasty. In addition, about 5% of patients undergoing tracheoplasty are expected to develop post-
operative stenosis.2 Therefore, from a rough estimate, about 200 patients per year could benefit from tracheal trans-
plantation in Brazil. In spite of being a small group, this pool of patients could achieve a definitive solution through 
tracheal transplantation.
However, besides the technical challenges, there are also ethical concerns. In order to be tested within a clinical 
scenario, tracheal transplantation needs to be at least as safe as airway prosthesis. Indeed, some researchers question 
the worth of expensive and technically demanding procedures for non-vital organ transplantation.1 Although recent 
advances have renewed the interest in tracheal transplantation among investigators, there are still some questions to 
be resolved before tracheal transplantation could be clinically useful. Nonetheless, we are sure that tracheal transplan-
tation will become an important procedure for dealing with complex airway lesions in the near future. 
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